Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 257

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Assessing pain intensity with the visual analog scale: A plea for uniformity

Reed, Michael D., Van Nostran, William·2014·The Journal of Clinical Pharmacology

Abstract

"Those who do not feel pain seldom think that it is felt." The sensation of pain is undeniably subjective. Personality, recollections of painful events, emotional state, age, culture, context, and other factors influence an individual's responses to, and description of, pain.1-5 Linguistically, the word "pain" encompasses multidimensional attributes well beyond a single sensation varying only in intensity.2, 3 Every patient's "pain vocabulary" contains nuanced connotations: aching, pulling, burning, stinging, stabbing, or radiating, to name a few.6 Quantifying "how much it hurts" eludes visual documentation (X-ray, MRI) or objective physiologic measurement (heart rate, blood pressure, hormone response, or other empirical information). No matter the clinical setting or circumstance, however, adequate pain management requires precise, thorough pain assessment—an individualized approach.4, 7-9 Assessing, treating, and monitoring pain is germane to every discipline—from general clinical practice through all subspecialties.10 Likewise, research assessing novel therapies and treatments pose additional challenges, particularly when changes in pain represent the primary outcome variable. The most credible expression of pain comes via each patient's self-report using their unique pain vocabulary.4, 6, 8 When cognitively and physically capable, the patient is the best source for accurately communicating the extent to which pain moderates, worsens, or varies over time.4, 6, 8 The European Palliative Care Research Collaborative, and scores of others charged with pain measurement, agree the most clinically relevant dimension to pain assessment, regardless of disease or condition, is pain intensity (PI).5, 7 A preponderance of evidence demonstrates that the 100 mm visual analog scale (VAS) is by far the most frequently used assessment instrument5, 8-11 to evaluate analgesic effects of various therapies and detect minute pain changes during analgesic administration. Structurally, we find the VAS a simple tool to use by anyone cognitively capable of understanding the parameters and responding to clinician instructions. Indeed its popularity is frequently attributed to the ease and convenience of the VAS in a fast-paced clinical setting.4 PI may be the most convenient dimension to assess quickly, but interpreting a VAS reading is no simple matter.12 Context plays an important role when translating a VAS score into an evidence-based treatment. One specialty treats nociceptive pain; another focuses on relieving patients suffering neuropathic pain.13 Hodgins2 and other authorities8 suggest that identical scores on a pain scale may be treated differently based on the specialty and individual patient.2 High pain scores may be termed acceptable immediately following traumatic injury, yet unacceptable if they persist over time.2, 3 The underlying cause of pain (surgery vs. migraine headache), and clinical setting (acute care vs. hospice) illustrates that no "one size fits all." Because VAS is an extremely common means of estimating and monitoring PI, it raises this conundrum: is VAS really the most effective assessment tool? Could flaws within the tool itself contaminate results? Or, might clinical interpretation of pain scores rob the VAS of consistency and reliability? We posit the tool and its clinical application combine to produce undependable, sometimes capricious results. Moreover, this variability and imprecision inherent in the standard VAS confounds extrapolation of findings from differing research investigations when applied to a global patient population. Ours is not an especially new or novel perspective. Authors representing diverse clinical and research domains have reported similar concerns over the decades.1, 2, 4, 7-16 Many clinicians and investigators consider the 100 mm continuum of the VAS (Figure 1A and B) superior in capturing subtle differences (sensitivity) compared to the few discrete points of categorical pain scales that limit responses to 4, 5, 7, or 11 choices8 (Figure 2A and B). Ironically, these investigators cannot reach consensus on which precise tick-mark on the 100 mm continuum corresponds to clinically relevant "moderate pain." 3, 5, 9, 14 Studies differ on what is considered a moderate pain threshold, beginning with >30 mm, up to >60 and even >75 mm.14, 17 Similarly, Stinson et al15 question whether a difference of 10 mm represents a meaningful change in PI. Williams et al8 report the meaning of identical tick-marks on a scale vary by patient. One individual's number expresses "average, everyday pain." A second patient considers the same VAS location as "barely tolerable."18 Several studies describe a "ceiling and floor" effect—a clustering of results around lower and higher endpoint descriptors.1, 8, 18 Our own recent use of the VAS19 supports the interpretive difficulties Stinson and colleagues cite.17, 18 This is further supported by investigators who point out that pain is not a linear phe

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/jcph.250

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 257

Metadata

Authors
Reed, M. D., & Van Nostran, W.
Venue
The Journal of Clinical Pharmacology
Publisher
Wiley
Published
2014-01-23
Volume
54
Issue
3
Pages
241-244
ISSN
  • 0021-9754 (ISSN-L)
  • 0091-2700
  • 1552-4604
OpenAlex
W2121920550
Cited by
257
References
19
FWCI
4.75
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.